Hualan Biological Engineering Statistics

Total Valuation

Hualan Biological Engineering has a market cap or net worth of CNY 29.72 billion. The enterprise value is 29.08 billion.

Market Cap	29.72B
Enterprise Value	29.08B

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jun 14, 2024

Share Statistics

Hualan Biological Engineering has 1.83 billion shares outstanding. The number of shares has increased by 0.15% in one year.

Shares Outstanding	1.83B
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	+0.53%
Owned by Insiders (%)	18.46%
Owned by Institutions (%)	14.20%
Float	963.39M

Valuation Ratios

The trailing PE ratio is 21.31 and the forward PE ratio is 19.58. Hualan Biological Engineering's PEG ratio is 1.29.

PE Ratio	21.31
Forward PE	19.58
PS Ratio	5.49
PB Ratio	2.64
P/FCF Ratio	115.89
PEG Ratio	1.29

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.87, with an EV/FCF ratio of 113.40.

EV / Earnings	20.84
EV / Sales	5.38
EV / EBITDA	14.87
EV / EBIT	17.14
EV / FCF	113.40

Financial Position

The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.08.

Current Ratio	3.86
Quick Ratio	2.41
Debt / Equity	0.08
Debt / EBITDA	0.54
Debt / FCF	4.13
Interest Coverage	112.07

Financial Efficiency

Return on equity (ROE) is 12.98% and return on invested capital (ROIC) is 7.69%.

Return on Equity (ROE)	12.98%
Return on Assets (ROA)	7.04%
Return on Capital (ROIC)	7.69%
Revenue Per Employee	1.46M
Profits Per Employee	376,145
Employee Count	3,709
Asset Turnover	0.36
Inventory Turnover	1.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.54% in the last 52 weeks. The beta is 0.34, so Hualan Biological Engineering's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-24.54%
50-Day Moving Average	15.52
200-Day Moving Average	18.14
Relative Strength Index (RSI)	54.15
Average Volume (20 Days)	15,688,017

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hualan Biological Engineering had revenue of CNY 5.41 billion and earned 1.40 billion in profits. Earnings per share was 0.76.

Revenue	5.41B
Gross Profit	3.50B
Operating Income	1.70B
Pretax Income	1.92B
Net Income	1.40B
EBITDA	1.96B
EBIT	1.70B
Earnings Per Share (EPS)	0.76

Full Income Statement

Balance Sheet

The company has 3.65 billion in cash and 1.06 billion in debt, giving a net cash position of 2.59 billion or 1.42 per share.

Cash & Cash Equivalents	3.65B
Total Debt	1.06B
Net Cash	2.59B
Net Cash Per Share	1.42
Equity (Book Value)	13.21B
Book Value Per Share	6.15
Working Capital	6.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 899.79 million and capital expenditures -643.37 million, giving a free cash flow of 256.42 million.

Operating Cash Flow	899.79M
Capital Expenditures	-643.37M
Free Cash Flow	256.42M
FCF Per Share	0.14

Full Cash Flow Statement

Margins

Gross margin is 64.77%, with operating and profit margins of 31.36% and 25.79%.

Gross Margin	64.77%
Operating Margin	31.36%
Pretax Margin	35.56%
Profit Margin	25.79%
EBITDA Margin	36.15%
EBIT Margin	31.36%
FCF Margin	4.74%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.78%.

Dividend Per Share	0.30
Dividend Yield	1.78%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	33.90%
Buyback Yield	-0.15%
Shareholder Yield	1.62%
Earnings Yield	4.69%
FCF Yield	0.86%

Dividend Details

Stock Splits

The last stock split was on April 27, 2020. It was a forward split with a ratio of 1.3.

Last Split Date	Apr 27, 2020
Split Type	Forward
Split Ratio	1.3

Scores

Hualan Biological Engineering has an Altman Z-Score of 11.29.

Altman Z-Score	11.29
Piotroski F-Score	n/a